Citations (69)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (17)
Katsuya Okada, Yi Zhou, Noriyasu Hashida, Tatsuya Takagi & Yu-Shi Tian. (2023) The Efficacy of Golimumab Against Non-Infectious Uveitis: A PRISMA-Compliant Systematic Review and Meta-Analysis. Ocular Immunology and Inflammation 31:5, pages 1013-1023.
Read now
Read now
Shivam H. Patel, Aditya Belamkar, Amir R. Hajrasouliha, Denis Jusufbegovic & Thomas A. Ciulla. (2022) Progress in the pharmacotherapy of uveitis: the art of personalized care. Expert Opinion on Pharmacotherapy 23:12, pages 1445-1455.
Read now
Read now
Ruchika Lakra, Amravi Shah, Viswanath Kaushik, Jyotirmay Biswas & Parthopratim Dutta Majumder. (2021) Use of Anti-Tumour Necrosis Factor-Alpha Agents in the Management of HLA-B-27-Associated Uveitis: The First Case Series from India. Ocular Immunology and Inflammation 29:2, pages 232-236.
Read now
Read now
Carla Gaggiano, Jurgen Sota, Stefano Gentileschi, Valeria Caggiano, Salvatore Grosso, Gian Marco Tosi, Bruno Frediani, Luca Cantarini & Claudia Fabiani. (2020) The current status of biological treatment for uveitis. Expert Review of Clinical Immunology 16:8, pages 787-811.
Read now
Read now
Maria Soledad Ormaechea, Muhammad Hassan, Neil Onghanseng, Jung Hyun Park, Sarakshi Mahajan, Khalid Yusuf Al-Kirwi, Gunay Uludag, Muhammad Sohail Halim, Ariel Schlaen, Yasir J Sepah, Diana V Do & Quan Dong Nguyen. (2019) Safety of systemic therapy for noninfectious uveitis. Expert Opinion on Drug Safety 18:12, pages 1219-1235.
Read now
Read now
Julie Gueudry, Jennifer E. Thorne, Rakesh Bansie, Juergen Braun, P. Martin van Hagen & Bahram Bodaghi. (2017) Biologic Therapy for HLA-B27-associated Ocular Disorders. Ocular Immunology and Inflammation 25:2, pages 169-178.
Read now
Read now
Denis Wakefield, William Yates, Shahriar Amjadi & Peter McCluskey. (2016) HLA-B27 Anterior Uveitis: Immunology and Immunopathology. Ocular Immunology and Inflammation 24:4, pages 450-459.
Read now
Read now
Arash Maleki, Halea Meese, Haitham Sahawneh & C. Stephen Foster. (2016) Progress in the understanding and utilization of biologic response modifiers in the treatment of uveitis. Expert Review of Clinical Immunology 12:7, pages 775-786.
Read now
Read now
Ivan Foeldvari. (2016) Managing uveitis in patients with juvenile idiopathic arthritis. Expert Opinion on Orphan Drugs 4:7, pages 741-745.
Read now
Read now
Andrea Taddio, Marco Cattalini, Gabriele Simonini & Rolando Cimaz. (2016) Recent advances in the use of Anti-TNFα therapy for the treatment of juvenile idiopathic arthritis. Expert Review of Clinical Immunology 12:6, pages 641-649.
Read now
Read now
Victor Llorenç, Marina Mesquida, Maite Sainz de la Maza, Ricardo Blanco, Vanesa Calvo, Olga Maíz, Ana Blanco, Juan Ramón de Dios-Jiménez de Aberásturi & Alfredo Adán. (2016) Certolizumab Pegol, a New Anti-TNF-α in the Armamentarium against Ocular Inflammation. Ocular Immunology and Inflammation 24:2, pages 167-172.
Read now
Read now
Khawla Abu Samra, Haitham Sahawneh & C. Stephen Foster. (2016) The role of biologic response modifiers in the management of juvenile idiopathic arthritis associated uveitis: a review. Expert Review of Ophthalmology 11:2, pages 155-163.
Read now
Read now
Valeria Kheir, Jean Vaudaux & Yan Guex-Crosier. (2016) Review of the latest systemic treatments for chronic non-infectious uveitis. Expert Review of Ophthalmology 11:2, pages 111-133.
Read now
Read now
Rowayda M. Amin, Elisabetta Miserocchi, Jennifer E. Thorne, Dana Hornbeak, Douglas A. Jabs & Manfred Zierhut. (2016) Treatment Options for Juvenile Idiopathic Arthritis (JIA) Associated Uveitis. Ocular Immunology and Inflammation 24:1, pages 81-90.
Read now
Read now
Robert J Barry, Quan Dong Nguyen, Richard W Lee, Philip I Murray & Alastair K Denniston. (2014) Pharmacotherapy for uveitis: current management and emerging therapy. Clinical Ophthalmology 8, pages 1891-1911.
Read now
Read now
Uwe Pleyer & Nicole Stübiger. (2014) New pharmacotherapy options for noninfectious posterior uveitis. Expert Opinion on Biological Therapy 14:12, pages 1783-1799.
Read now
Read now
Kyungmin Lee, Asima Bajwa, Clovis A Freitas-Neto, Jamie Lynne Metzinger, Bailey A Wentworth & C Stephen Foster. (2014) A comprehensive review and update on the biologic treatment of adult noninfectious uveitis: part II. Expert Opinion on Biological Therapy 14:11, pages 1651-1666.
Read now
Read now
Articles from other publishers (52)
Morgane Joubert, Anne-Claire Desbois, Fanny Domont, Amine Ghembaza, Alexandre Le Joncour, Adrien Mirouse, Georgina Maalouf, Mathilde Leclercq, Sarah Touhami, Patrice Cacoub, Bahram Bodaghi & David Saadoun. (2023) Behçet’s Disease Uveitis. Journal of Clinical Medicine 12:11, pages 3648.
Crossref
Crossref
Manuel Busto-Iglesias, Lorena Rodríguez-Martínez, Carmen Antía Rodríguez-Fernández, Jaime González-López, Miguel González-Barcia, Begoña de Domingo, Luis Rodríguez-Rodríguez, Anxo Fernández-Ferreiro & Cristina Mondelo-García. (2023) Perspectives of Therapeutic Drug Monitoring of Biological Agents in Non-Infectious Uveitis Treatment: A Review. Pharmaceutics 15:3, pages 766.
Crossref
Crossref
Xue Wu, Mengying Tao, Ling Zhu, Ting Zhang & Ming Zhang. (2022) Pathogenesis and current therapies for non-infectious uveitis. Clinical and Experimental Medicine 23:4, pages 1089-1106.
Crossref
Crossref
Arnd Heiligenhaus & Christoph Deuter. (2022) Uveitis bei juveniler idiopathischer Arthritis – leitliniengerechte Diagnostik und Therapie anhand von Kasuistiken. Klinische Monatsblätter für Augenheilkunde 239:05, pages 676-685.
Crossref
Crossref
Arnd Heiligenhaus, Christoph Tappeiner & Ulrich Neudorf. 2022. Pädiatrische Rheumatologie. Pädiatrische Rheumatologie
413
427
.
Sofia Lanz, Gerald Seidel & Andrea Skrabl-Baumgartner. (2021) Golimumab in juvenile idiopathic arthritis-associated uveitis unresponsive to Adalimumab. Pediatric Rheumatology 19:1.
Crossref
Crossref
Priya Janardhana & Saad Al-Kadhi. (2021) A review of ophthalmic manifestations of inflammatory bowel disease and associated treatments. Current Opinion in Ophthalmology 32:6, pages 549-554.
Crossref
Crossref
Yulu Li, Xiaolan Mao, Xuemei Tang & Huawei Mao. (2021) Efficacy and Safety of Anti-TNFα Therapy for Uveitis Associated with Juvenile Idiopathic Arthritis: A Systematic Review and Meta-Analysis. Rheumatology and Therapy 8:2, pages 711-727.
Crossref
Crossref
Julie Gueudry, Mathilde Leclercq, David Saadoun & Bahram Bodaghi. (2021) Old and New Challenges in Uveitis Associated with Behçet’s Disease. Journal of Clinical Medicine 10:11, pages 2318.
Crossref
Crossref
Lisia Barros Ferreira, Anthony J. SmithJustine R. Smith. (2021) Biologic Drugs for the Treatment of Noninfectious Uveitis. Asia-Pacific Journal of Ophthalmology 10:1, pages 63-73.
Crossref
Crossref
Arnd Heiligenhaus, Christoph Tappeiner & Ulrich Neudorf. 2020. Pädiatrische Rheumatologie. Pädiatrische Rheumatologie
1
15
.
Judith Rademacher, Uwe Pleyer & Sibylle Winterhalter. 2021. Entzündliche Augenerkrankungen. Entzündliche Augenerkrankungen
503
517
.
Alejandro Gómez-Gómez, Estíbaliz Loza, Mª Piedad Rosario, Gerard Espinosa, José M García Ruiz de Morales, José M Herrera, Santiago Muñoz-Fernández, Luis Rodríguez-Rodríguez & Miguel Cordero-Coma. (2020) Efficacy and safety of immunomodulatory drugs in patients with non-infectious intermediate and posterior uveitis, panuveitis and macular edema: A systematic literature review. Seminars in Arthritis and Rheumatism 50:6, pages 1299-1306.
Crossref
Crossref
Hana Malcová. (2020) Recommendations for the Management of Uveitis Associated with Juvenile Idiopathic Arthritis: The Czech and Slovak Adaptation of the Share Initiative. Czech and Slovak Ophthalmology 76:4, pages 182-196.
Crossref
Crossref
Monique Munro, Ann-Marie Lobo & Pooja Bhat. (2020) Pediatric Noninfectious Uveitis Medical Treatment Update. Advances in Ophthalmology and Optometry 5, pages 331-344.
Crossref
Crossref
Rodrigo A. Valenzuela, Iván Flores, Beatriz Urrutia, Francisca Fuentes, Pablo E. Sabat, Carolina Llanos, Loreto Cuitino & Cristhian A. Urzua. (2020) New Pharmacological Strategies for the Treatment of Non-Infectious Uveitis. A Minireview. Frontiers in Pharmacology 11.
Crossref
Crossref
Susumu Yamazaki, Asami Shimbo, Yuko Akutsu, Hiroshi Takase, Tomohiro Morio & Masaaki Mori. (2020) Importance of pediatric rheumatologists and transitional care for juvenile idiopathic arthritis-associated uveitis: a retrospective series of 9 cases. Pediatric Rheumatology 18:1.
Crossref
Crossref
Carla Gaggiano, Donato Rigante, Gian Marco Tosi, Antonio Vitale, Bruno Frediani, Salvatore Grosso, Claudia Fabiani & Luca Cantarini. (2019) Treating juvenile idiopathic arthritis (JIA)-related uveitis beyond TNF-α inhibition: a narrative review. Clinical Rheumatology 39:2, pages 327-337.
Crossref
Crossref
Amruta Trivedi & Constance Katelaris. (2019) The use of biologic agents in the management of uveitis. Internal Medicine Journal 49:11, pages 1352-1363.
Crossref
Crossref
A. Heiligenhaus, K. Minden, C. Tappeiner, H. Baus, B. Bertram, C. Deuter, I. Foeldvari, D. Föll, M. Frosch, G. Ganser, M. Gaubitz, A. Günther, C. Heinz, G. Horneff, C. Huemer, I. Kopp, C. Lommatzsch, T. Lutz, H. Michels, T. Neß, U. Neudorf, U. Pleyer, M. Schneider, H. Schulze-Koops, S. Thurau, M. Zierhut & H.W. Lehmann. (2019) Update of the evidence based, interdisciplinary guideline for anti-inflammatory treatment of uveitis associated with juvenile idiopathic arthritis. Seminars in Arthritis and Rheumatism 49:1, pages 43-55.
Crossref
Crossref
Mohammad Ali Shahab, Tahreem Aman Mir & Sidra Zafar. (2018) Optimising drug therapy for non-infectious uveitis. International Ophthalmology 39:7, pages 1633-1650.
Crossref
Crossref
Judy L. Chen, Ann-Marie Lobo-Chan, Robison Vernon Paul Chan & Pooja Bhat. 2019. Advances in the Diagnosis and Management of Uveitis. Advances in the Diagnosis and Management of Uveitis.
Muhammad Hassan, Samendra Karkhur, Jeong H. Bae, Muhammad S. Halim, Maria S. Ormaechea, Neil Onghanseng, Nam V. Nguyen, Rubbia Afridi, Yasir J. Sepah, Diana V. Do & Quan D. Nguyen. (2019) New therapies in development for the management of non‐infectious uveitis: A review. Clinical & Experimental Ophthalmology 47:3, pages 396-417.
Crossref
Crossref
Riccardo Sacconi, Chiara Giuffrè, Eleonora Corbelli, Enrico Borrelli, Giuseppe Querques & Francesco Bandello. (2019) Emerging therapies in the management of macular edema: a review. F1000Research 8, pages 1413.
Crossref
Crossref
Laura J. Kopplin & Amde Selassie Shifera. 2019. Treatment of Non-infectious Uveitis. Treatment of Non-infectious Uveitis
67
84
.
John A. Gonzales & Nisha Acharya. 2019. Posterior Uveitis. Posterior Uveitis
175
207
.
Robert J Barry, Mohammad O Tallouzi, Nick Bucknall, Jonathan M Mathers, Philip I Murray, Melanie J Calvert, David J Moore & Alastair K Denniston. (2018) Anti-tumour necrosis factor biological therapies for the treatment of uveitic macular oedema (UMO) for non-infectious uveitis. Cochrane Database of Systematic Reviews 2018:12.
Crossref
Crossref
Martina Biggioggero, Chiara Crotti, Andrea Becciolini, Elisabetta Miserocchi & Ennio Giulio Favalli. (2018) The Management of Acute Anterior Uveitis Complicating Spondyloarthritis: Present and Future. BioMed Research International 2018, pages 1-11.
Crossref
Crossref
Hana Malcová, Rudolf Horváth & Pavla Doležalová. (2018) Current possibilities of biologic therapy in paediatric rheumatology. Pediatrie pro praxi 19:2, pages 91-96.
Crossref
Crossref
ParthopratimDutta Majumder, Ruchika Lakra, G Yamuna, AnindyaKishore Majumder & Viswanath Kaushik. (2018) A case of human leukocyte antigen B-27-associated ocular hypotony successfully treated with golimumab. Indian Journal of Ophthalmology 66:7, pages 1006.
Crossref
Crossref
Resham Pattani. (2018) Paediatric eye care Part 2 – Uveitis. Optician 2018:1, pages 6860-1.
Crossref
Crossref
Mohammad O Tallouzi, Robert J Barry, Nick Bucknall, Jonathan M Mathers, Philip I Murray, Melanie J Calvert, David J Moore & Alastair K Denniston. (2017) Anti-tumour necrosis factor biological therapies for the treatment of uveitic macular oedema (UMO) for non-infectious uveitis. Cochrane Database of Systematic Reviews.
Crossref
Crossref
Arjun B. Sood & Sheila T. Angeles-Han. (2017) An Update on Treatment of Pediatric Chronic Non-infectious Uveitis. Current Treatment Options in Rheumatology 3:1, pages 1-16.
Crossref
Crossref
Serpil Yazgan, Ugur Celik, Metin Işık, Nesibe Karahan Yeşil, Ali Erdem Baki, Hatice Şahin, Ercan Gencer & İsmail Doğan. (2016) Efficacy of golimumab on recurrent uveitis in HLA-B27-positive ankylosing spondylitis. International Ophthalmology 37:1, pages 139-145.
Crossref
Crossref
Shih-Chou Chen & Shwu-Jiuan Sheu. (2017) Recent advances in managing and understanding uveitis. F1000Research 6, pages 280.
Crossref
Crossref
Joyce J. Hsu, Tzielan C. Lee & Christy I. Sandborg. 2017. Kelley and Firestein's Textbook of Rheumatology. Kelley and Firestein's Textbook of Rheumatology
1826
1843.e6
.
Sergio Schwartzman. 2017. Uveitis. Uveitis
301
316
.
Claudia Fabiani, Antonio Vitale, Giuseppe Lopalco, Florenzo Iannone, Bruno Frediani & Luca Cantarini. (2016) Different roles of TNF inhibitors in acute anterior uveitis associated with ankylosing spondylitis: state of the art. Clinical Rheumatology 35:11, pages 2631-2638.
Crossref
Crossref
Vanesa Calvo-Río, Ricardo Blanco, Montserrat Santos-Gómez, Esteban Rubio-Romero, Miguel Cordero-Coma, Adela Gallego-Flores, Raúl Veroz, Ignacio Torre, Félix Francisco Hernández, Antonio Atanes, Javier Loricera, M.C. González-Vela, Natalia Palmou, José L. Hernández & Miguel A. González-Gay. (2016) Golimumab in refractory uveitis related to spondyloarthritis. Multicenter study of 15 patients. Seminars in Arthritis and Rheumatism 46:1, pages 95-101.
Crossref
Crossref
A. Heiligenhaus, C. Tappeiner, K. Walscheid & C. Heinz. (2016) Juvenile idiopathische Arthritis-assoziierte UveitisUveitis associated with juvenile idiopathic arthritis. Der Ophthalmologe 113:5, pages 391-397.
Crossref
Crossref
Robert Eisenberg & Edward M. Behrens. 2016. Pediatric Allergy: Principles and Practice. Pediatric Allergy: Principles and Practice
160
166.e4
.
Angelo RavelliAngelo Ravelli. 2016. Handbook of Juvenile Idiopathic Arthritis. Handbook of Juvenile Idiopathic Arthritis
87
114
.
Jared E. Knickelbein, Karen R. Armbrust, Meredith Kim, H. Nida Sen & Robert B. Nussenblatt. 2017. Pharmacologic Therapy of Ocular Disease. Pharmacologic Therapy of Ocular Disease
231
268
.
Leyre Riancho-Zarrabeitia, Vanesa Calvo-Río, Ricardo Blanco, Marina Mesquida, Alfredo M. Adan, José M. Herreras, Ángel Aparicio, Diana Peiteado-Lopez, Miguel Cordero-Coma, José Luis García Serrano, Norberto Ortego-Centeno, Olga Maíz, Ana Blanco, Juan Sánchez-Bursón, Senén González-Suárez, Alejandro Fonollosa, Montserrat Santos-Gómez, Carmen González-Vela, Javier Loricera, Trinitario Pina & Miguel A. González-Gay. (2015) Anti-TNF-α therapy in refractory uveitis associated with sarcoidosis: Multicenter study of 17 patients. Seminars in Arthritis and Rheumatism 45:3, pages 361-368.
Crossref
Crossref
Sergio Schwartzman & Monica Schwartzman. (2014) The Use of Biologic Therapies in Uveitis. Clinical Reviews in Allergy & Immunology 49:3, pages 307-316.
Crossref
Crossref
Francesco Caso, Luisa Costa, Antonio Del Puente, Matteo Nicola Dario Di Minno, Gelsy Lupoli, Raffaele Scarpa & Rosario Peluso. (2015) Pharmacological treatment of spondyloarthritis: exploring the effectiveness of nonsteroidal anti-inflammatory drugs, traditional disease-modifying antirheumatic drugs and biological therapies. Therapeutic Advances in Chronic Disease 6:6, pages 328-338.
Crossref
Crossref
Miguel Cordero-Coma & Lucia Sobrin. (2015) Anti–tumor necrosis factor-α therapy in uveitis. Survey of Ophthalmology 60:6, pages 575-589.
Crossref
Crossref
Stefan Siebert, Alexander Tsoukas, Jamie Robertson & Iain McInnes. (2015) Cytokines as Therapeutic Targets in Rheumatoid Arthritis and Other Inflammatory Diseases. Pharmacological Reviews 67:2, pages 280-309.
Crossref
Crossref
Laura J. Kopplin, Amde S. Shifera, Eric B. Suhler & Phoebe Lin. (2015) Biological Response Modifiers in the Treatment of Noninfectious Uveitis. International Ophthalmology Clinics 55:2, pages 19-36.
Crossref
Crossref
Percival D. Sampaio-Barros & Irene E. van der Horst-Bruinsma. (2014) Adverse effects of TNF inhibitors in SpA: Are they different from RA?. Best Practice & Research Clinical Rheumatology 28:5, pages 747-763.
Crossref
Crossref
Rosa Bou, Estíbaliz Iglesias & Jordi Antón. (2014) Treatment of Uveitis Associated with Juvenile Idiopathic Arthritis. Current Rheumatology Reports 16:8.
Crossref
Crossref
. (2014) Golimumab. Reactions Weekly 1500:1, pages 20-20.
Crossref
Crossref